•
Mar 31, 2020

Acadia Healthcare Q1 2020 Earnings Report

Acadia Healthcare's first quarter performance met expectations despite challenges from the COVID-19 pandemic, with revenue increasing and the company taking measures to ensure patient and employee safety.

Key Takeaways

Acadia Healthcare reported a 2.9% increase in revenue for the first quarter of 2020, reaching $782.8 million. Net income attributable to Acadia stockholders was $33.5 million, or $0.38 per diluted share. The company withdrew its full-year 2020 guidance due to COVID-19 uncertainty but remains confident in its long-term growth opportunities.

Revenue increased by 2.9% to $782.8 million compared to Q1 2019.

Net income attributable to Acadia stockholders was $33.5 million, or $0.38 per diluted share.

Adjusted income attributable to Acadia stockholders per diluted share was $0.42.

The company withdrew its full-year 2020 financial guidance due to the uncertainty related to the COVID-19 pandemic.

Total Revenue
$783M
Previous year: $761M
+2.9%
EPS
$0.42
Previous year: $0.39
+7.7%
US Same Facility Revenue Growth
4.1%
US Same Facility Patient Days Growth
2.9%
US Rev. per Patient Day Growth
1.2%
Gross Profit
$311M
Previous year: $301M
+3.1%
Cash and Equivalents
$81M
Previous year: $43.7M
+85.4%
Free Cash Flow
-$12.9M
Previous year: -$25.6M
-49.6%
Total Assets
$6.72B
Previous year: $6.79B
-1.0%

Acadia Healthcare

Acadia Healthcare

Forward Guidance

Due to the uncertainty related to the COVID-19 pandemic, Acadia withdrew its 2020 financial guidance.